Short Interest in XOMA Co. (NASDAQ:XOMAP) Declines By 22.2%

XOMA Co. (NASDAQ:XOMAP) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 2,100 shares, a decline of 22.2% from the March 31st total of 2,700 shares. Based on an average daily trading volume, of 1,400 shares, the short-interest ratio is presently 1.5 days.

XOMA Stock Up 0.4 %

XOMA stock opened at $25.06 on Tuesday. XOMA has a one year low of $21.40 and a one year high of $25.98. The business has a fifty day moving average price of $25.03 and a 200-day moving average price of $24.28.

XOMA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Wednesday, April 3rd were given a dividend of $0.5391 per share. This represents a $2.16 annualized dividend and a dividend yield of 8.60%. The ex-dividend date was Tuesday, April 2nd.

About XOMA

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.